HDAC9 and type 2 diabetes mellitus: In recent years, increasing evidence demonstrates a substantial influence of HDACs on glucose and lipid metabolism, potentially qualifying pharmacological modulation of HDAC activity as an approach to counteract metabolic disorders including obesity and type 2 diabetes.